Richard Harris
Pain Medicine · Sparks, NVNPI 1447315882
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 9.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for pain medicine clinicians in NV, where the typical reported total is $2,557.
Across 169 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$292
- Biodelivery Sciences International, Inc.$268
- Saol Therapeutics Inc.$247
- AbbVie$230
- Scilex Pharmaceuticals Inc.$226
- Collegium Pharmaceutical, Inc.$186
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,102100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $292 |
| Biodelivery Sciences International, Inc. | 29 | $268 |
| Saol Therapeutics Inc. | 4 | $247 |
| AbbVie(2 entities) | 14 | $230 |
| Scilex Pharmaceuticals Inc. | 14 | $226 |
| Collegium Pharmaceutical, Inc. | 11 | $186 |
| Tersera Therapeutics LLC | 8 | $151 |
| Merz North America, Inc. | 6 | $135 |
| Supernus Pharmaceuticals, Inc. | 8 | $135 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $131 |
| Amgen(2 entities) | 6 | $126 |
| Stimwave Technologies Incorporated | 2 | $123 |
| Ipsen Biopharmaceuticals, Inc | 4 | $103 |
| Merz Pharmaceuticals, LLC | 3 | $97 |
| Pacira Therapeutics, Inc. | 5 | $94 |
| Biohaven Pharmaceuticals, Inc. | 5 | $86 |
| Novartis | 5 | $72 |
| GRT US Holding, Inc. | 3 | $61 |
| Pfizer | 3 | $59 |
| Redhill Biopharma Inc. | 3 | $55 |
| Alnylam Pharmaceuticals Inc. | 3 | $53 |
| Sanofi-aventis U.S. LLC | 1 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Medtronic(2 entities) | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Forte Bio-pharma LLC | 1 | $13 |
| Baudax Bio Inc. | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$3,102 in reported general payments places this provider in the 50th percentile of 101 pain medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 48 | $1,028 |
| Morphine Sulfate ErMorphine Sulfate | 26 | $622 |
| Gabapentin | 13 | $129 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Sparks
- Jeffrey ZollingerSparks$4K
- Denis PattersonReno$816K
- Rainer VogelHenderson$230K
- John DimuroPahrump$44K
- Anwar MackReno$32K
- Kunal ParikhLas Vegas$26K
- Hashim QureshiN Las Vegas$25K
- Nader HelmiLas Vegas$25K
- Jonathan BurnsReno$20K
- Sungkook ParkLas Vegas$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.